<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04067050</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-105</org_study_id>
    <nct_id>NCT04067050</nct_id>
  </id_info>
  <brief_title>A Clinical Study of the Comfilcon A Asphere Soft Contact Lens in Users of Digital Devices</brief_title>
  <official_title>A Clinical Study of the Biofinity Energys Soft Contact Lens in Users of Digital Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this work is to investigate the clinical performance and subjective acceptance of
      the comfilcon A asphere contact lens when compared to single-vision spectacles in subjects
      who have never worn contact lenses and who use digital devices (such as phones, tablets,
      laptops, desktop computers) for at least 4 hours per day on at least 5 days per week.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this clinical work is to compare the clinical performance and subjective
      acceptance of comfilcon A asphere contact lens when compared to single-vision spectacles in
      subjects who use digital devices (phones, tablets, laptops, desktop computers) for at least 4
      hours per day on at least 5 days per week. Subjects will be randomized to use either their
      habitual spectacles or the study contact lenses for two months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 4, 2019</start_date>
  <completion_date type="Actual">March 30, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom of Burning</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of burning measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Itching</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of itching measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Feeling of Foreign Body</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of feeling of foreign body measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Tearing</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of tearing measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Excessive Blinking</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of excessive blinking measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Eye Redness</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of eye redness measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Eye Pain</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of eye pain measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Heavy Eyelids</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of heavy eyelids measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Dryness</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of dryness measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Blurred Vision</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of blurred vision measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Double Vision</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of double vision measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Difficulty Focusing For Near Vision</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of difficulty focusing for near vision measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Increased Sensitivity to Light</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of increased sensitivity to light measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Colored Halos Around Objects</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of colored halos around objects measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of Feeling That Sight is Worsening</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of feeling that sight is worsening measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom of headache</measure>
    <time_frame>Up to 2 months</time_frame>
    <description>Symptom of headache measured by frequency (never=does not occur at all, occasionally=sporadic episodes/once a week, or often/always=2 or 3 times a week/almost every day) and intensity (measured by: moderate or intense when symptom is experienced).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Ametropia</condition>
  <arm_group>
    <arm_group_label>comfilcon A asphere</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will wear their comfilcon A asphere contact lenses for two months. Lenses will be worn on a daily wear, reusable basis for at least 8 hours per day, 5 days per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Habitual Spectacles</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will wear their single vision habitual spectacles for two months for at least 8 hours per day, 5 days per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comfilcon A asphere</intervention_name>
    <description>Contact Lens</description>
    <arm_group_label>comfilcon A asphere</arm_group_label>
    <other_name>test</other_name>
    <other_name>Biofinity Energys</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spectacles</intervention_name>
    <description>Habitual spectacles</description>
    <arm_group_label>Habitual Spectacles</arm_group_label>
    <other_name>Control</other_name>
    <other_name>Single Vision Spectacles</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  They are between 18 and 35 years of age (inclusive).

          -  They understand their rights as a research subject and are willing and able to sign a
             Statement of Informed Consent.

          -  They are willing and able to follow the protocol.

          -  They are a 'neophyte' (i.e. someone who has not worn contact lenses previously, with
             the exception for the purposes of a trial fitting, lasting up to one week).

          -  They have a contact lens spherical prescription between -1.00 to -6.25D (inclusive)
             based on the ocular refraction.

          -  They have a cylindrical correction of -0.875DC or less in each eye based on the ocular
             refraction

          -  They own and habitually wear single vision spectacles used for both distance and near
             vision, including computer and digital device use.

          -  Their single vision spectacles have a mean sphere equivalent within Â±0.50D of that of
             the refraction found in the study for each eye (after having taken lens effectivity
             into account).

          -  They are willing to be fitted with contact lenses and understand they may be
             randomized to either group.

          -  They are willing to wear the contact lenses (if relevant) or spectacles for at least 8
             hours per day, 5 days per week.

          -  They typically use digital devices for a minimum of 4 hours per day, 5 days per week.

          -  They agree not to change the spectacles they will wear for digital device use for the
             duration of the study.

          -  They agree not to participate in other clinical research for the duration of the
             study.

        Exclusion Criteria:

          -  They have an ocular disorder which would normally contra-indicate contact lens wear.

          -  They have a systemic disorder which would normally contra-indicate contact lens wear.

          -  They are using any topical medication such as eye drops (including comfort drops) or
             ointment on a regular basis.

          -  The spectacles they use for digital device viewing on the study have been made with
             specialist features for computer use, digital eye fatigue or are multifocal/bifocal.

          -  They are aphakic.

          -  They have had corneal refractive surgery.

          -  They have any corneal distortion resulting from previous hard or rigid lens wear or
             have keratoconus.

          -  They are pregnant or breastfeeding.

          -  They have any infectious disease which would, in the opinion of the investigator,
             contraindicate contact lens wear or pose a risk to study personnel; or they have any
             immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic
             reaction.

          -  They have evidence of a heterotropia or decompensating heterotropia on cover test.

          -  They have a history of having been prescribed prism in their spectacles (by self
             report).

          -  They have taken part in any other contact lens or care solution clinical trial or
             research, within two weeks prior to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eurolens Research - The University of Manchester</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9PL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>August 21, 2019</study_first_submitted>
  <study_first_submitted_qc>August 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2019</study_first_posted>
  <last_update_submitted>May 1, 2020</last_update_submitted>
  <last_update_submitted_qc>May 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

